<!DOCTYPE html>
<html lang="en"><head>
<script src="Lecture1_files/libs/clipboard/clipboard.min.js"></script>
<script src="Lecture1_files/libs/quarto-html/tabby.min.js"></script>
<script src="Lecture1_files/libs/quarto-html/popper.min.js"></script>
<script src="Lecture1_files/libs/quarto-html/tippy.umd.min.js"></script>
<link href="Lecture1_files/libs/quarto-html/tippy.css" rel="stylesheet">
<link href="Lecture1_files/libs/quarto-html/light-border.css" rel="stylesheet">
<link href="Lecture1_files/libs/quarto-html/quarto-html.min.css" rel="stylesheet" data-mode="light">
<link href="Lecture1_files/libs/quarto-html/quarto-syntax-highlighting.css" rel="stylesheet" id="quarto-text-highlighting-styles">
<link href="Lecture1_files/libs/quarto-contrib/fontawesome6-0.1.0/all.css" rel="stylesheet">
<link href="Lecture1_files/libs/quarto-contrib/fontawesome6-0.1.0/latex-fontsize.css" rel="stylesheet">
<script src="Lecture1_files/libs/quarto-contrib/glightbox/glightbox.min.js"></script>
<link href="Lecture1_files/libs/quarto-contrib/glightbox/glightbox.min.css" rel="stylesheet">
<link href="Lecture1_files/libs/quarto-contrib/glightbox/lightbox.css" rel="stylesheet"><meta charset="utf-8">
  <meta name="generator" content="quarto-1.4.552">

  <title>lecture1</title>
  <meta name="apple-mobile-web-app-capable" content="yes">
  <meta name="apple-mobile-web-app-status-bar-style" content="black-translucent">
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=no, minimal-ui">
  <link rel="stylesheet" href="Lecture1_files/libs/revealjs/dist/reset.css">
  <link rel="stylesheet" href="Lecture1_files/libs/revealjs/dist/reveal.css">
  <style>
    code{white-space: pre-wrap;}
    span.smallcaps{font-variant: small-caps;}
    div.columns{display: flex; gap: min(4vw, 1.5em);}
    div.column{flex: auto; overflow-x: auto;}
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
    ul.task-list{list-style: none;}
    ul.task-list li input[type="checkbox"] {
      width: 0.8em;
      margin: 0 0.8em 0.2em -1em; /* quarto-specific, see https://github.com/quarto-dev/quarto-cli/issues/4556 */ 
      vertical-align: middle;
    }
    /* CSS for citations */
    div.csl-bib-body { }
    div.csl-entry {
      clear: both;
      margin-bottom: 0em;
    }
    .hanging-indent div.csl-entry {
      margin-left:2em;
      text-indent:-2em;
    }
    div.csl-left-margin {
      min-width:2em;
      float:left;
    }
    div.csl-right-inline {
      margin-left:2em;
      padding-left:1em;
    }
    div.csl-indent {
      margin-left: 2em;
    }  </style>
  <link rel="stylesheet" href="Lecture1_files/libs/revealjs/dist/theme/quarto.css">
  <link href="Lecture1_files/libs/revealjs/plugin/quarto-line-highlight/line-highlight.css" rel="stylesheet">
  <link href="Lecture1_files/libs/revealjs/plugin/reveal-menu/menu.css" rel="stylesheet">
  <link href="Lecture1_files/libs/revealjs/plugin/reveal-menu/quarto-menu.css" rel="stylesheet">
  <link href="Lecture1_files/libs/revealjs/plugin/reveal-chalkboard/font-awesome/css/all.css" rel="stylesheet">
  <link href="Lecture1_files/libs/revealjs/plugin/reveal-chalkboard/style.css" rel="stylesheet">
  <link href="Lecture1_files/libs/revealjs/plugin/quarto-support/footer.css" rel="stylesheet">
  <style type="text/css">

  .callout {
    margin-top: 1em;
    margin-bottom: 1em;  
    border-radius: .25rem;
  }

  .callout.callout-style-simple { 
    padding: 0em 0.5em;
    border-left: solid #acacac .3rem;
    border-right: solid 1px silver;
    border-top: solid 1px silver;
    border-bottom: solid 1px silver;
    display: flex;
  }

  .callout.callout-style-default {
    border-left: solid #acacac .3rem;
    border-right: solid 1px silver;
    border-top: solid 1px silver;
    border-bottom: solid 1px silver;
  }

  .callout .callout-body-container {
    flex-grow: 1;
  }

  .callout.callout-style-simple .callout-body {
    font-size: 1rem;
    font-weight: 400;
  }

  .callout.callout-style-default .callout-body {
    font-size: 0.9rem;
    font-weight: 400;
  }

  .callout.callout-titled.callout-style-simple .callout-body {
    margin-top: 0.2em;
  }

  .callout:not(.callout-titled) .callout-body {
      display: flex;
  }

  .callout:not(.no-icon).callout-titled.callout-style-simple .callout-content {
    padding-left: 1.6em;
  }

  .callout.callout-titled .callout-header {
    padding-top: 0.2em;
    margin-bottom: -0.2em;
  }

  .callout.callout-titled .callout-title  p {
    margin-top: 0.5em;
    margin-bottom: 0.5em;
  }
    
  .callout.callout-titled.callout-style-simple .callout-content  p {
    margin-top: 0;
  }

  .callout.callout-titled.callout-style-default .callout-content  p {
    margin-top: 0.7em;
  }

  .callout.callout-style-simple div.callout-title {
    border-bottom: none;
    font-size: .9rem;
    font-weight: 600;
    opacity: 75%;
  }

  .callout.callout-style-default  div.callout-title {
    border-bottom: none;
    font-weight: 600;
    opacity: 85%;
    font-size: 0.9rem;
    padding-left: 0.5em;
    padding-right: 0.5em;
  }

  .callout.callout-style-default div.callout-content {
    padding-left: 0.5em;
    padding-right: 0.5em;
  }

  .callout.callout-style-simple .callout-icon::before {
    height: 1rem;
    width: 1rem;
    display: inline-block;
    content: "";
    background-repeat: no-repeat;
    background-size: 1rem 1rem;
  }

  .callout.callout-style-default .callout-icon::before {
    height: 0.9rem;
    width: 0.9rem;
    display: inline-block;
    content: "";
    background-repeat: no-repeat;
    background-size: 0.9rem 0.9rem;
  }

  .callout-title {
    display: flex
  }
    
  .callout-icon::before {
    margin-top: 1rem;
    padding-right: .5rem;
  }

  .callout.no-icon::before {
    display: none !important;
  }

  .callout.callout-titled .callout-body > .callout-content > :last-child {
    padding-bottom: 0.5rem;
    margin-bottom: 0;
  }

  .callout.callout-titled .callout-icon::before {
    margin-top: .5rem;
    padding-right: .5rem;
  }

  .callout:not(.callout-titled) .callout-icon::before {
    margin-top: 1rem;
    padding-right: .5rem;
  }

  /* Callout Types */

  div.callout-note {
    border-left-color: #4582ec !important;
  }

  div.callout-note .callout-icon::before {
    background-image: url('data:image/png;base64,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');
  }

  div.callout-note.callout-style-default .callout-title {
    background-color: #dae6fb
  }

  div.callout-important {
    border-left-color: #d9534f !important;
  }

  div.callout-important .callout-icon::before {
    background-image: url('data:image/png;base64,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');
  }

  div.callout-important.callout-style-default .callout-title {
    background-color: #f7dddc
  }

  div.callout-warning {
    border-left-color: #f0ad4e !important;
  }

  div.callout-warning .callout-icon::before {
    background-image: url('data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAACAAAAAgCAYAAABzenr0AAAAAXNSR0IArs4c6QAAAERlWElmTU0AKgAAAAgAAYdpAAQAAAABAAAAGgAAAAAAA6ABAAMAAAABAAEAAKACAAQAAAABAAAAIKADAAQAAAABAAAAIAAAAACshmLzAAAETklEQVRYCeVWW2gcVRg+58yaTUnizqbipZeX4uWhBEniBaoUX1Ioze52t7sRq6APio9V9MEaoWlVsFasRq0gltaAPuxms8lu0gcviE/FFOstVbSIxgcv6SU7EZqmdc7v9+9mJtNks51NTUH84ed889/PP+cmxP+d5FIbMJmNbpREu4WUkiTtCicKny0l1pIKmBzovF2S+hIJHX8iEu3hZJ5lNZGqyRrGSIQpq15AzF28jgpeY6yk6GVdrfFqdrD6Iw+QlB8g0YS2g7dyQmXM/IDhBhT0UCiRf59lfqmmDvzRt6kByV/m4JjtzuaujMUM2c5Z2d6JdKrRb3K2q6mA+oYVz8JnDdKPmmNthzkAk/lN63sYPgevrguc72aZX/L9C6x09GYyxBgCX4NlvyGUHOKELlm5rXeR1kchuChJt4SSwyddZRXgvwMGvYo4QSlk3/zkHD8UHxwVJA6zjZZqP8v8kK8OWLnIZtLyCAJagYC4rTGW/9Pqj92N/c+LUaAj27movwbi19tk/whRCIE7Q9vyI6yvRpftAKVTdUjOW40X3h5OXsKCdmFcx0xlLJoSuQngnrJe7Kcjm4OMq9FlC7CMmScQANuNvjfP3PjGXDBaUQmbp296S5L4DrpbrHN1T87ZVEZVCzg1FF0Ft+dKrlLukI+/c9ENo+TvlTDbYFvuKPtQ9+l052rXrgKoWkDAFnvh0wTOmYn8R5f4k/jN/fZiCM1tQx9jQQ4ANhqG4hiL0qIFTGViG9DKB7GYzgubnpofgYRwO+DFjh0Zin2m4b/97EDkXkc+f6xYAPX0KK2I/7fUQuwzuwo/L3AkcjugPNixC8cHf0FyPjWlItmLxWw4Ou9YsQCr5fijMGoD/zpdRy95HRysyXA74MWOnscpO4j2y3HAVisw85hX5+AFBRSHt4ShfLFkIMXTqyKFc46xdzQM6XbAi702a7sy04J0+feReMFKp5q9esYLCqAZYw/k14E/xcLLsFElaornTuJB0svMuJINy8xkIYuL+xPAlWRceH6+HX7THJ0djLUom46zREu7tTkxwmf/FdOZ/sh6Q8qvEAiHpm4PJ4a/doJe0gH1t+aHRgCzOvBvJedEK5OFE5jpm4AGP2a8Dxe3gGJ/pAutug9Gp6he92CsSsWBaEcxGx0FHytmIpuqGkOpldqNYQK8cSoXvd+xLxXADw0kf6UkJNFtdo5MOgaLjiQOQHcn+A6h5NuL2s0qsC2LOM75PcF3yr5STuBSAcGG+meA14K/CI21HcS4LBT6tv0QAh8Dr5l93AhZzG5ZJ4VxAqdZUEl9z7WJ4aN+svMvwHHL21UKTd1mqvChH7/Za5xzXBBKrUcB0TQ+Ulgkfbi/H/YT5EptrGzsEK7tR1B7ln9BBwckYfMiuSqklSznIuoIIOM42MQO+QnduCoFCI0bpkzjCjddHPN/F+2Yu+sd9bKNpVwHhbS3LluK/0zgfwD0xYI5dXuzlQAAAABJRU5ErkJggg==');
  }

  div.callout-warning.callout-style-default .callout-title {
    background-color: #fcefdc
  }

  div.callout-tip {
    border-left-color: #02b875 !important;
  }

  div.callout-tip .callout-icon::before {
    background-image: url('data:image/png;base64,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');
  }

  div.callout-tip.callout-style-default .callout-title {
    background-color: #ccf1e3
  }

  div.callout-caution {
    border-left-color: #fd7e14 !important;
  }

  div.callout-caution .callout-icon::before {
    background-image: url('data:image/png;base64,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');
  }

  div.callout-caution.callout-style-default .callout-title {
    background-color: #ffe5d0
  }

  </style>
  <style type="text/css">
    .reveal div.sourceCode {
      margin: 0;
      overflow: auto;
    }
    .reveal div.hanging-indent {
      margin-left: 1em;
      text-indent: -1em;
    }
    .reveal .slide:not(.center) {
      height: 100%;
      overflow-y: auto;
    }
    .reveal .slide.scrollable {
      overflow-y: auto;
    }
    .reveal .footnotes {
      height: 100%;
      overflow-y: auto;
    }
    .reveal .slide .absolute {
      position: absolute;
      display: block;
    }
    .reveal .footnotes ol {
      counter-reset: ol;
      list-style-type: none; 
      margin-left: 0;
    }
    .reveal .footnotes ol li:before {
      counter-increment: ol;
      content: counter(ol) ". "; 
    }
    .reveal .footnotes ol li > p:first-child {
      display: inline-block;
    }
    .reveal .slide ul,
    .reveal .slide ol {
      margin-bottom: 0.5em;
    }
    .reveal .slide ul li,
    .reveal .slide ol li {
      margin-top: 0.4em;
      margin-bottom: 0.2em;
    }
    .reveal .slide ul[role="tablist"] li {
      margin-bottom: 0;
    }
    .reveal .slide ul li > *:first-child,
    .reveal .slide ol li > *:first-child {
      margin-block-start: 0;
    }
    .reveal .slide ul li > *:last-child,
    .reveal .slide ol li > *:last-child {
      margin-block-end: 0;
    }
    .reveal .slide .columns:nth-child(3) {
      margin-block-start: 0.8em;
    }
    .reveal blockquote {
      box-shadow: none;
    }
    .reveal .tippy-content>* {
      margin-top: 0.2em;
      margin-bottom: 0.7em;
    }
    .reveal .tippy-content>*:last-child {
      margin-bottom: 0.2em;
    }
    .reveal .slide > img.stretch.quarto-figure-center,
    .reveal .slide > img.r-stretch.quarto-figure-center {
      display: block;
      margin-left: auto;
      margin-right: auto; 
    }
    .reveal .slide > img.stretch.quarto-figure-left,
    .reveal .slide > img.r-stretch.quarto-figure-left  {
      display: block;
      margin-left: 0;
      margin-right: auto; 
    }
    .reveal .slide > img.stretch.quarto-figure-right,
    .reveal .slide > img.r-stretch.quarto-figure-right  {
      display: block;
      margin-left: auto;
      margin-right: 0; 
    }
  </style>
</head>
<body class="quarto-light">
  <div class="reveal">
    <div class="slides">


<section id="lecture-1-penicllin-and-antibiotic-allergies" class="slide level2" data-background-image="images/nejm_allergy.png" data-background-opacity="0.2">
<h2>Lecture 1: Penicllin and antibiotic allergies</h2>
<p><br> <br> <br> <br> <br></p>
<p><strong>Russell E. Lewis</strong> <br> Associate Professor of Infectious Diseases <br> Department of Molecular Medicine <br> University of Padua</p>
<p><a href="images/unipd.png" class="lightbox" data-gallery="quarto-lightbox-gallery-1"><img data-src="images/unipd.png" class="absolute" style="top: 550px; left: 950px; width: 100px; height: 100px; "></a></p>
<p><br> <i class="fa-solid fa-envelope fa-1x" aria-label="envelope"></i> russelledward.lewis@unipd.it <br> <i class="fa-brands fa-github fa-1x" aria-label="github"></i> <a href="https://github.com/Russlewisbo/ESCMID_2022_talk">https://github.com/Russlewisbo</a></p>
</section>
<section id="objectives" class="slide level2">
<h2>Objectives</h2>
<ul>
<li><p>Describe the different types of hypersensitivity reactions based on clinical presentation and immunological mechanisms&nbsp;</p></li>
<li><p>Recognise a patient history that will differentiate between immediate and delayed-type hypersensitivity reactions&nbsp;</p></li>
<li><p>Describe the risk of cross-reactions between various beta-lactam antibiotics&nbsp;</p></li>
<li><p>Describe the principles and contraindications for desensitisation</p></li>
<li><p>Describe the clinical manifestations, diagnosis and management of common non-beta-lactam antibiotic allergies</p></li>
</ul>
</section>
<section id="on-target-vs.-off-target-drug-effects" class="slide level2">
<h2>On target vs.&nbsp;off-target drug effects</h2>
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/classification.png" class="lightbox" data-gallery="quarto-lightbox-gallery-2"><img data-src="images/classification.png" class="quarto-figure quarto-figure-center"></a></p>
</figure>
</div>

<aside><div>
<p><span class="citation" data-cites="macy.etal_2023">(<a href="#/references" role="doc-biblioref" onclick="">Macy et al., 2023</a>)</span></p>
</div></aside></section>
<section id="variable-cutaneous-presentation-of-allergic-drug-reactions" class="slide level2">
<h2>Variable cutaneous presentation of <br>allergic drug reactions</h2>
<p><br></p>
<div class="columns">
<div class="column" style="width:25%;">
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/widespreadmacular.png" class="lightbox" data-glightbox="description: .lightbox-desc-3" data-gallery="quarto-lightbox-gallery-3" title="widespread macupapular"><img data-src="images/widespreadmacular.png" alt="widespread macupapular"></a></p>
<figcaption>widespread macupapular</figcaption>
</figure>
</div>
</div><div class="column" style="width:25%;">
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/macupapular%20aspect.png" class="lightbox" data-glightbox="description: .lightbox-desc-4" data-gallery="quarto-lightbox-gallery-4" title="macupapular aspect"><img data-src="images/macupapular%20aspect.png" alt="macupapular aspect"></a></p>
<figcaption>macupapular aspect</figcaption>
</figure>
</div>
</div><div class="column" style="width:25%;">
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/isolated%20foilicular.png" class="lightbox" data-glightbox="description: .lightbox-desc-5" data-gallery="quarto-lightbox-gallery-5" title="isolated follicular"><img data-src="images/isolated%20foilicular.png" alt="isolated follicular"></a></p>
<figcaption>isolated follicular</figcaption>
</figure>
</div>
</div><div class="column" style="width:25%;">
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/coelscing%20erythema.png" class="lightbox" data-glightbox="description: .lightbox-desc-6" data-gallery="quarto-lightbox-gallery-6" title="coalescing erythema"><img data-src="images/coelscing%20erythema.png" alt="coalescing erythema"></a></p>
<figcaption>coalescing erythema</figcaption>
</figure>
</div>
</div>
</div>

<aside><div>
<p>Images: Kathrin Hoffmeier Sherer, M.D., Univ. of Basel</p>
</div></aside></section>
<section id="urticaria-and-angioedema" class="slide level2 smaller">
<h2>Urticaria and angioedema</h2>
<p><br></p>
<div class="columns">
<div class="column" style="width:50%;">
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/urticaria.png" class="lightbox" data-glightbox="description: .lightbox-desc-7" data-gallery="quarto-lightbox-gallery-7" title="urticaria"><img data-src="images/urticaria.png" alt="urticaria"></a></p>
<figcaption>urticaria</figcaption>
</figure>
</div>
</div><div class="column" style="width:50%;">
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/angioendema.png" class="lightbox" data-glightbox="description: .lightbox-desc-8" data-gallery="quarto-lightbox-gallery-8" title="angioedema"><img data-src="images/angioendema.png" alt="angioedema"></a></p>
<figcaption>angioedema</figcaption>
</figure>
</div>
</div>
</div>

<aside><div>
<p>Images: Kathrin Hoffmeier Sherer, M.D., Univ. of Basel</p>
</div></aside></section>
<section id="acute-generalised-exanthematous-pustulosis-agep" class="slide level2">
<h2><strong>Acute generalised exanthematous pustulosis (AGEP)</strong></h2>
<p><br> <br></p>
<div class="columns">
<div class="column" style="width:50%;">
<p><a href="images/ten.png" class="lightbox" data-gallery="quarto-lightbox-gallery-9"><img data-src="images/ten.png"></a></p>
</div><div class="column" style="width:50%;">
<p><a href="images/agep.png" class="lightbox" data-gallery="quarto-lightbox-gallery-10"><img data-src="images/agep.png"></a></p>
</div>
</div>

<aside><div>
<p><span class="citation" data-cites="zhang.liu_2015">(<a href="#/references" role="doc-biblioref" onclick="">Zhang and Liu, 2015</a>)</span></p>
</div></aside></section>
<section id="fixed-drug-eruption" class="slide level2">
<h2>Fixed drug eruption</h2>
<p><br></p>
<p><a href="images/fixed.png" class="lightbox" data-gallery="quarto-lightbox-gallery-11"><img data-src="images/fixed.png"></a></p>

<aside><div>
<p>Image: Kathrin Hoffmeier Sherer, M.D., Univ. of Basel</p>
</div></aside></section>
<section id="erythema-multiforme-toxic-epidermal-necrolysis-ten" class="slide level2">
<h2><strong>Erythema multiforme, Toxic epidermal necrolysis (TEN)</strong></h2>
<p><br></p>
<p><a href="images/ten2.png" class="lightbox" data-gallery="quarto-lightbox-gallery-12"><img data-src="images/ten2.png"></a></p>

<aside><div>
<p>Image: Kathrin Hoffmeier Sherer, M.D., Univ. of Basel</p>
</div></aside></section>
<section id="dress-drug-rash-with-eosinophilia-and-systemic-symptoms" class="slide level2 smaller">
<h2><strong>DRESS: Drug rash with eosinophilia</strong> <br> and systemic symptoms</h2>
<div class="columns">
<div class="column" style="width:40%;">
<ul>
<li><p><strong>Latency:</strong> 2-8 weeks</p></li>
<li><p><strong>Non-specific symptoms:</strong></p>
<ul>
<li>Fever (75%), lymphadenopathy (55-65%)</li>
</ul></li>
<li><p><strong>Hematological abnormalities:</strong></p>
<ul>
<li><p><strong>Eosinophilia &gt; 700 micolL (85-95%)</strong></p></li>
<li><p><strong>Leukocytosis (95%)</strong></p></li>
<li><p><strong>Neutrophilia (78%)</strong></p></li>
<li><p><strong>Monocytosis (69%)</strong></p></li>
<li><p><strong>Atypical lymphocytosis (35-67%)</strong></p></li>
</ul></li>
<li><p><strong>Visceral involvement:</strong></p>
<ul>
<li><p><strong>Liver (53-90%)-cholestatic and/or hepatocellular</strong></p></li>
<li><p><strong>Pulmonary (30%)-shortness of breath, cough</strong></p></li>
<li><p><strong>Cardiac involvement (2-20%)- hypotension, tachycardia, dyspnea, LV dysfunction, myocarditis</strong></p></li>
</ul></li>
</ul>
</div><div class="column" style="width:60%;">
<p><a href="images/dress.png" class="lightbox" data-gallery="quarto-lightbox-gallery-13"><img data-src="images/dress.png"></a></p>
</div>
</div>

<aside><div>
<p>Image: UptoDate</p>
</div></aside></section>
<section id="dress-pathophysiology-and-systemic-symptoms" class="slide level2 smaller">
<h2>DRESS: Pathophysiology <br> and systemic symptoms</h2>
<p><br> <br></p>
<div class="columns">
<div class="column" style="width:40%;">
<ul>
<li><p><strong>Pathophysiology:</strong></p>
<ul>
<li><p>Type IV T-cell activation (CD4+/CD8+) producing TNF-α</p></li>
<li><p>Reactivation of viruses from the Herpesviridae family (eg, HHV-6, HHV-7, Epstein-Barr virus [EBV], cytomegalovirus [CMV]) occurs in up to 75 percent of patients-cause or consequence?&nbsp;</p></li>
<li><p>Some patient human leukocyte antigens are associated with higher risk</p></li>
</ul></li>
</ul>
</div><div class="column" style="width:60%;">
<p><a href="images/dress.png" class="lightbox" data-gallery="quarto-lightbox-gallery-14"><img data-src="images/dress.png"></a></p>
</div>
</div>

<aside><div>
<p>Image: UptoDate</p>
</div></aside></section>
<section id="classic-high-risk-drugs-for-dress" class="slide level2">
<h2>Classic “high-risk” drugs for DRESS</h2>
<p><br></p>
<ul>
<li><p>Allopurinol</p></li>
<li><p>Aromatic antiepileptic agents (carbamazepine, phenytoin, lamotrigine, …)</p></li>
<li><p>Sulfonamides</p></li>
<li><p>Vancomycin</p></li>
<li><p>Minocycline</p></li>
<li><p>Nevirapine</p></li>
<li><p>Anti-tuberculosis drugs</p></li>
<li><p>Mexiletine</p></li>
</ul>
<p><strong>β-lactams are lower risk</strong></p>
</section>
<section id="stevens-johnson-syndrome" class="slide level2">
<h2>Stevens-Johnson Syndrome</h2>
<p><br> <br></p>
<p><a href="images/SJ.png" class="lightbox" data-gallery="quarto-lightbox-gallery-15"><img data-src="images/SJ.png"></a></p>

<aside><div>
<p>Image: Kathrin Hoffmeier Sherer, M.D., Univ. of Basel</p>
</div></aside></section>
<section id="modified-gell-and-coombs-classification" class="slide level2">
<h2>Modified Gell and Coombs Classification</h2>
<p><br></p>
<p><a href="images/coombs.png" class="lightbox" data-gallery="quarto-lightbox-gallery-16"><img data-src="images/coombs.png" width="800"></a></p>

<aside><div>
<p><span class="citation" data-cites="hausmann.etal_2010">(<a href="#/references" role="doc-biblioref" onclick="">Hausmann et al., 2010</a>)</span></p>
</div></aside></section>
<section id="immunological-mechanisms" class="slide level2 smaller">
<h2>Immunological mechanisms <br></h2>
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/nejm2.png" class="lightbox" data-gallery="quarto-lightbox-gallery-17"><img data-src="images/nejm2.png" class="quarto-figure quarto-figure-center" width="400"></a></p>
</figure>
</div>

<aside><div>
<p><span class="citation" data-cites="castells.etal_2019">(<a href="#/references" role="doc-biblioref" onclick="">Castells et al., 2019</a>)</span></p>
</div></aside></section>
<section id="penicillin-allergy" class="slide level2" data-background-image="images/amoxicillin.png" data-background-opacity="0.2">
<h2><br> <br> <br> <br> Penicillin allergy</h2>
</section>
<section id="penicillin-allergy-epidemiology" class="slide level2">
<h2>Penicillin allergy epidemiology</h2>
<p><br></p>
<ul>
<li><p>10-20% of patients will report a history of an allergy to PCN therapy&nbsp;</p></li>
<li><p>However, only 0.5%-2% of all PCN administrations actually result in hypersensitivity reactions, most often rash&nbsp;</p>
<ul>
<li>Of these 1% are IgE mediated&nbsp;</li>
</ul></li>
<li><p>The incidence IgE PCN allergies is decreasing, partially due to the reduced use of parenteral PCN, which degradation products in solution may be the primary culprit&nbsp;</p></li>
<li><p>Statistics from the UK 1972-2007 oral amoxicillin:</p>
<ul>
<li>1 death after anaphylaxis with oral amoxicillin (35 years and 100 million treatment courses)</li>
</ul></li>
<li><p>Most reports of penicillin allergy describe unknown or cutaneous reaction</p></li>
</ul>
<p><br></p>
</section>
<section id="public-health-implications" class="slide level2 smaller">
<h2>Public health implications</h2>
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/public.png" class="lightbox" data-gallery="quarto-lightbox-gallery-18"><img data-src="images/public.png" class="quarto-figure quarto-figure-center" width="800"></a></p>
</figure>
</div>

<aside><div>
<p><span class="citation" data-cites="castells.etal_2019">(<a href="#/references" role="doc-biblioref" onclick="">Castells et al., 2019</a>)</span></p>
</div></aside></section>
<section id="so-if-a-patient-reports-they-have-a-penicillin-allergy" class="slide level2 smaller">
<h2>So if a patient reports they have a <br> penicillin allergy…</h2>
<p><br></p>
<div class="columns">
<div class="column" style="width:50%;">
<p><strong>5% need allergy evaluation</strong></p>
<ul>
<li><p>Recent history if true IgE type reaction</p></li>
<li><p>Blistering rash</p></li>
<li><p>Hemolytic anemia</p></li>
<li><p>Nephritis</p></li>
<li><p>Hepatitis</p></li>
<li><p>Fever and joint pain</p></li>
<li><p>Severe cutaneous adverse reaction (SCAR)</p></li>
</ul>
</div><div class="column" style="width:50;">
<p><strong>95% can tolerate penicillins</strong></p>
<ul>
<li>Delayed, benign rash (Type IV reaction) that often does not recur with rechallenge</li>
<li>True IgE reactions wane over time, with 80% becoming tolerant after 10 years&nbsp;</li>
<li>Many patients were never allergic, but had other symptoms they though represented a PCN allergy (concurrent viral infection, GI distress)</li>
</ul>
</div>
</div>
</section>
<section id="top-4-patient-penicillin-allergy-myths" class="slide level2" data-background-image="images/amoxicillin.png" data-background-opacity="0.2">
<h2>Top 4 patient penicillin allergy myths</h2>
<p><br></p>
<ul>
<li><p><strong>Once you have an penicillin allergy, you have it for life</strong></p>
<ul>
<li>Allergy wanes over time, 80% of patients with type I (IgE-mediated reactions) will not have an allergy after a 10 year period</li>
</ul></li>
<li><p><strong>Viral rashes mistaken for antibiotic therapy</strong></p>
<ul>
<li><p>E.g., child with a viral exanthematous rash treated with a course of penicillin</p></li>
<li><p>Pediatric studies have reported &gt;90% of children who developed rashes on antibiotic therapy do not develop a rash when rechallenged with penicillin again</p></li>
</ul></li>
<li><p><strong>Adverse effects mistaken by the patient as drug allergy</strong></p>
<ul>
<li>E.g. diarrhea, stomach cramps</li>
</ul></li>
<li><p><strong>“I have a family history of penicillin allergy”</strong></p>
<ul>
<li>No genetic basis has been identified for penicillin allergies</li>
</ul></li>
</ul>
</section>
<section id="penicillin-allergy-history" class="slide level2">
<h2>Penicillin allergy history</h2>
<p><br></p>
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/history.png" class="lightbox" data-gallery="quarto-lightbox-gallery-19"><img data-src="images/history.png" class="quarto-figure quarto-figure-center"></a></p>
</figure>
</div>

<p><br></p>
<aside><div>
<p><span class="citation" data-cites="shenoy.etal_2019">(<a href="#/references" role="doc-biblioref" onclick="">Shenoy et al., 2019</a>)</span></p>
</div></aside></section>
<section id="timing-and-clinical-presentation-of-reaction-is-key" class="slide level2">
<h2>Timing and clinical presentation of reaction is key</h2>
<p><br></p>
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/contraindications.png" class="lightbox" data-gallery="quarto-lightbox-gallery-20"><img data-src="images/contraindications.png" class="quarto-figure quarto-figure-center"></a></p>
</figure>
</div>

<aside><div>
<p><span class="citation" data-cites="shenoy.etal_2019">(<a href="#/references" role="doc-biblioref" onclick="">Shenoy et al., 2019</a>)</span></p>
</div></aside></section>
<section id="how-to-assess-patient-risk" class="slide level2">
<h2>How to assess patient risk</h2>
<p><br></p>
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/risk.png" class="lightbox" data-gallery="quarto-lightbox-gallery-21"><img data-src="images/risk.png" class="quarto-figure quarto-figure-center"></a></p>
</figure>
</div>

<aside><div>
<p><span class="citation" data-cites="shenoy.etal_2019">(<a href="#/references" role="doc-biblioref" onclick="">Shenoy et al., 2019</a>)</span></p>
</div></aside></section>
<section id="penfast-score" class="slide level2 smaller">
<h2>PENFAST score</h2>
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/penfast.png" class="lightbox" data-gallery="quarto-lightbox-gallery-22"><img data-src="images/penfast.png" class="quarto-figure quarto-figure-center" width="800"></a></p>
</figure>
</div>

<aside><div>
<p>The PEN-FAST clinical decision rule for patients reporting a penicillin allergy uses 3 clinical criteria of time from penicillin allergy episode, phenotype, and treatment required. A total score is calculated using PEN-FAST score in the upper panel,and interpretation for risk strategy is provided in the lower panel. <sup>a</sup>Includes unknown. <sup>b</sup>Forms of severe delayed reactions include potential Stevens-Johnsonsyndrome, toxic epidermalnecrolysis, drug reaction witheosinophilia and systemicsymptoms, and acute generalizedexanthematous pustulosis. Patients with a severe delayed rash withmucosal involvement should beconsidered to have a severecutaneous adverse reaction. Acute interstitial nephritis, drug inducedliver injury, serum sickness andisolated drug fever were excluded phenotypes from the derivation and validation cohorts.</p>
<p><span class="citation" data-cites="trubiano.etal_2020">(<a href="#/references" role="doc-biblioref" onclick="">Trubiano et al., 2020</a>)</span></p>
</div></aside></section>
<section id="penfast-performance" class="slide level2">
<h2>PENFAST performance</h2>
<p><br></p>
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/penfast_perf.png" class="lightbox" data-gallery="quarto-lightbox-gallery-23"><img data-src="images/penfast_perf.png" class="quarto-figure quarto-figure-center"></a></p>
</figure>
</div>

<aside><div>
<p><span class="citation" data-cites="trubiano.etal_2020">(<a href="#/references" role="doc-biblioref" onclick="">Trubiano et al., 2020</a>)</span></p>
</div></aside></section>
<section id="direct-oral-amoxicillin-challenge" class="slide level2">
<h2>Direct oral amoxicillin challenge</h2>
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/amox_challenge.png" class="lightbox" data-gallery="quarto-lightbox-gallery-24"><img data-src="images/amox_challenge.png" class="quarto-figure quarto-figure-center"></a></p>
</figure>
</div>

<aside><div>
<p><span class="citation" data-cites="macy.etal_2023">(<a href="#/references" role="doc-biblioref" onclick="">Macy et al., 2023</a>)</span></p>
</div></aside></section>
<section id="palace-study" class="slide level2">
<h2>Palace study</h2>
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/Palace.png" class="lightbox" data-gallery="quarto-lightbox-gallery-25"><img data-src="images/Palace.png" class="quarto-figure quarto-figure-center"></a></p>
</figure>
</div>

<aside><div>
<p><span class="citation" data-cites="copaescu.etal_2023">(<a href="#/references" role="doc-biblioref" onclick="">Copaescu et al., 2023</a>)</span></p>
</div></aside></section>
<section id="two-step-oral-amoxicillin-challenge" class="slide level2">
<h2>Two step oral amoxicillin challenge</h2>
<p><br></p>
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/2step.png" class="lightbox" data-gallery="quarto-lightbox-gallery-26"><img data-src="images/2step.png" class="quarto-figure quarto-figure-center"></a></p>
</figure>
</div>

<aside><div>
<p><span class="citation" data-cites="macy.etal_2023">(<a href="#/references" role="doc-biblioref" onclick="">Macy et al., 2023</a>)</span></p>
</div></aside></section>
<section id="anaphylaxis-medications" class="slide level2">
<h2>Anaphylaxis medications</h2>
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/anaphylaxis.png" class="lightbox" data-gallery="quarto-lightbox-gallery-27"><img data-src="images/anaphylaxis.png" class="quarto-figure quarto-figure-center"></a></p>
</figure>
</div>

<aside><div>
<p><span class="citation" data-cites="macy.etal_2023">(<a href="#/references" role="doc-biblioref" onclick="">Macy et al., 2023</a>)</span></p>
</div></aside></section>
<section id="how-to-assess-patient-risk-1" class="slide level2">
<h2>How to assess patient risk</h2>
<p><br></p>
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/risk.png" class="lightbox" data-gallery="quarto-lightbox-gallery-28"><img data-src="images/risk.png" class="quarto-figure quarto-figure-center"></a></p>
</figure>
</div>

<aside><div>
<p><span class="citation" data-cites="shenoy.etal_2019">(<a href="#/references" role="doc-biblioref" onclick="">Shenoy et al., 2019</a>)</span></p>
</div></aside></section>
<section id="skin-testing" class="slide level2">
<h2>Skin testing</h2>
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/skintest.png" class="lightbox" data-gallery="quarto-lightbox-gallery-29"><img data-src="images/skintest.png" class="quarto-figure quarto-figure-center"></a></p>
</figure>
</div>

<aside><div>
<p><span class="citation" data-cites="macy.etal_2023">(<a href="#/references" role="doc-biblioref" onclick="">Macy et al., 2023</a>)</span></p>
</div></aside></section>
<section id="allergic-determinates" class="slide level2 smaller">
<h2>Allergic determinates</h2>
<div class="columns">
<div class="column" style="width:50%;">
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/penicillins.png" class="lightbox" data-gallery="quarto-lightbox-gallery-30"><img data-src="images/penicillins.png" class="quarto-figure quarto-figure-center" width="250"></a></p>
</figure>
</div>
</div><div class="column" style="width:50%;">
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/minor.png" class="lightbox" data-gallery="quarto-lightbox-gallery-31"><img data-src="images/minor.png" class="quarto-figure quarto-figure-center" width="250"></a></p>
</figure>
</div>
</div>
</div>

<aside><div>
<p><span class="citation" data-cites="castells.etal_2019">(<a href="#/references" role="doc-biblioref" onclick="">Castells et al., 2019</a>)</span></p>
</div></aside></section>
<section id="penicillin-skin-test-asssessment" class="slide level2">
<h2>Penicillin skin test asssessment</h2>
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/skintest2.png" class="lightbox" data-gallery="quarto-lightbox-gallery-32"><img data-src="images/skintest2.png" class="quarto-figure quarto-figure-center"></a></p>
</figure>
</div>

<aside><div>
<p><span class="citation" data-cites="macy.etal_2023">(<a href="#/references" role="doc-biblioref" onclick="">Macy et al., 2023</a>)</span></p>
</div></aside></section>
<section id="penicillin-skin-test-assessment-medium-risk-history" class="slide level2">
<h2>Penicillin skin test assessment-Medium risk history</h2>
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/medium%20risk.png" class="lightbox" data-gallery="quarto-lightbox-gallery-33"><img data-src="images/medium%20risk.png" class="quarto-figure quarto-figure-center"></a></p>
</figure>
</div>

<aside><div>
<p><span class="citation" data-cites="macy.etal_2023">(<a href="#/references" role="doc-biblioref" onclick="">Macy et al., 2023</a>)</span></p>
</div></aside></section>
<section id="how-do-these-test-impact-medium-risk-patients" class="slide level2">
<h2>How do these test impact “medium risk” patients?</h2>
<p><br></p>
<ul>
<li>A negative skin test is associated with a 95% NPV for PCN allergy</li>
<li>A negative skin test plus negative amoxicillin challenge approaches 100% NPV for PCN allergy</li>
<li>If skin test is positive, amoxicillin challenge is not considered</li>
<li>Patient should be referred to an allergy/immunologist or desensitisation considered</li>
</ul>
</section>
<section id="desensitization" class="slide level2">
<h2>Desensitization</h2>
<p><br></p>
<ul>
<li>Progressive, graded degranulation of mast cells (histamine release) by administering graded doses of antibiotic</li>
<li>Desensitization is contraindicated in patients with a history of a penicillin-induced exfoliative dermatitis, Stevens-Johnson syndrome, or toxic epidermal necrolysis</li>
<li>Desensitization has no effect on the incidence of non-IgE mediated reactions such as serum sickness, hemolytic anemia, maculopapular rashes, drug fever, hepatitis, or interstitial nephritis</li>
<li>If the patient does not receive a dose for a period of more than 24 hours, the risk for an immediate IgE-mediated reaction can be restored and repeat desensitization is required if the same drug is to be used again</li>
</ul>
</section>
<section id="sample-desensitization-protocol" class="slide level2">
<h2>Sample desensitization protocol</h2>
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/meropenem.png" class="lightbox" data-gallery="quarto-lightbox-gallery-34"><img data-src="images/meropenem.png" class="quarto-figure quarto-figure-center"></a></p>
</figure>
</div>

<aside><div>
<p>Source: MD Anderson Cancer Center, Houston, Texas</p>
</div></aside></section>
<section id="other-desensitization-protocols" class="slide level2">
<h2>Other desensitization protocols</h2>
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/Sanford.png" class="lightbox" data-gallery="quarto-lightbox-gallery-35"><img data-src="images/Sanford.png" class="quarto-figure quarto-figure-center"></a></p>
</figure>
</div>
</section>
<section id="cross-reactivity-infectious-diseases-dogma" class="slide level2">
<h2>Cross-reactivity: Infectious diseases dogma</h2>
<div class="columns">
<div class="column" style="width:50%;">
<ul>
<li>Common teaching: If a patient has a documented PCN allergy, the risk of cross reactions with cephalosporins is 10%</li>
<li>THIS IS FALSE, the actual cross reactivity is more likely 2%-3%
<ul>
<li>A subset of patients with history of anaphylaxis may have cross-reactivity determined by the R1 sidechain of the molecule</li>
<li>Cefazolin as a unique side chain and and very low risk for cross-reactivity</li>
</ul></li>
</ul>
</div><div class="column" style="width:50%;">
<p><a href="images/sidechains.png" class="lightbox" data-gallery="quarto-lightbox-gallery-36"><img data-src="images/sidechains.png"></a></p>
</div>
</div>
<p><br></p>
</section>
<section id="risk-of-cross-reactivity-related-to-cephalosporin-sidechain" class="slide level2">
<h2>Risk of cross-reactivity related to cephalosporin sidechain</h2>
<p><br></p>
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/cross-reactivity.png" class="lightbox" data-gallery="quarto-lightbox-gallery-37"><img data-src="images/cross-reactivity.png" class="quarto-figure quarto-figure-center"></a></p>
</figure>
</div>

<aside><div>
<p>Source: Stanford University Hospital Antimicrobial Stewardship</p>
</div></aside></section>
<section id="what-is-the-cross-reactivity-with-carbapenems" class="slide level2">
<h2>What is the cross-reactivity with carbapenems?</h2>
<p><br></p>
<ul>
<li>Cross reactivity with penicillin allergy and carbapenems is less than 1%</li>
<li>No cross reactivity between penicillins and monobactams (aztreonam)</li>
<li>A graded challenge or test dose can be considered:
<ul>
<li>i.e.&nbsp;Infuse 5-10% of dose and observe patient, then progress to full dose if not reaction</li>
<li>Skin testing (if available) could also rule out allergies</li>
</ul></li>
</ul>
</section>
<section id="special-populations-that-should-be-considered-for-testing" class="slide level2 smaller">
<h2>Special populations that should be <br> considered for testing</h2>
<p><br></p>
<ul>
<li><strong>Peri-procedure before elective surgery</strong>
<ul>
<li>Importance of antibiotic timing/tissue levels at time of incision-less optimal with vancomycin that requires longer infusion</li>
</ul></li>
<li><strong>Pregnancy</strong>
<ul>
<li>PCN allergy associated with increased risk of cesarean delivery, post-cesarean wound complications, and longer length of stay</li>
<li>Consider third trimester referral for testing in patients with planned cesarean delivery, group B streptococcus colonization</li>
</ul></li>
<li><strong>Long term care facilities</strong>
<ul>
<li>Non-beta-lactam based therapies have higher risk for drug interactions</li>
<li>Higher risk for adverse effects</li>
</ul></li>
<li><strong>Hematology-oncology</strong>
<ul>
<li>Consider testing before chemotherapy or transplant (onset of of immunosuppression)</li>
</ul></li>
<li><strong>STD clinics</strong></li>
<li><strong>ICU patients?</strong></li>
</ul>
</section>
<section id="non-penicillin-allergies" class="slide level2" data-background-image="images/TMPSMX.png" data-background-opacity="0.2">
<h2><br> <br> <br> <br> Non-penicillin allergies?</h2>
</section>
<section id="similar-principles--patient-history-is-key" class="slide level2">
<h2>Similar principles- patient history is key</h2>
<p><br></p>
<ul>
<li>Which drugs was the patient taking?</li>
<li>Dates of intake</li>
<li>Exact sequence of events</li>
<li>Underlying disease/Concomitant infections</li>
<li>Other drug administered at the same time/concomitant infections</li>
<li>Clinical morphology (at several time points)of rash</li>
<li>Histology of eosinophilia?</li>
</ul>
</section>
<section id="intradermal-testing-non-beta-lactams" class="slide level2">
<h2>Intradermal testing-Non beta-lactams</h2>
<div class="columns">
<div class="column" style="width:50%;">
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/intradermal.png" class="lightbox" data-gallery="quarto-lightbox-gallery-38"><img data-src="images/intradermal.png" class="quarto-figure quarto-figure-center"></a></p>
</figure>
</div>
</div><div class="column" style="width:50%;">
<ul>
<li>Prick and intradermal tests less well standardized S</li>
<li>Some antibiotics are irritating even at low concentrations, making testing difficult</li>
<li>Special cellular activation tests may be available in some centers for some drugs</li>
</ul>
</div>
</div>

<aside><div>
<p>Image: Kathrin Hoffmeier Sherer, M.D., Univ. of Basel</p>
</div></aside></section>
<section id="approach-to-delayed-type-hypersensitivity-testing" class="slide level2">
<h2>Approach to delayed-type hypersensitivity testing</h2>
<div class="columns">
<div class="column" style="width:50%;">
<p><a href="images/Patch.png" class="lightbox" data-gallery="quarto-lightbox-gallery-39"><img data-src="images/Patch.png"></a></p>
</div><div class="column" style="width:50%;">
<ul>
<li>Intradermal or patch testing with reading 24-72 hours
<ul>
<li>Low sensitivity, high specificity</li>
</ul></li>
<li>Lymphocyte transformation testing
<ul>
<li>Available in specialized laboratories</li>
<li>Haptenization to become an antigen in vivo (hard to imitate in lab)</li>
</ul></li>
</ul>
</div>
</div>

<aside><div>
<p>Image: Kathrin Hoffmeier Sherer, M.D., Univ. of Basel</p>
</div></aside></section>
<section id="sulfonamide-hypersensitivity" class="slide level2">
<h2>Sulfonamide hypersensitivity</h2>
<p><br></p>
<ul>
<li>Incidence 8%</li>
<li>Primarily cutaneous and GI tract</li>
<li>Only 3% are considered true hypersensitivity reactions.
<ul>
<li>Most common presentations are limited exanthems and fixed drug eruptions</li>
<li>However…sulfonamides are disproportionately associated with infrequent severe side effects (i.e.&nbsp;TEN, Stevens-Johnson Syndrome)</li>
</ul></li>
<li>Mechanisms IgE-mediated are known to occur, but other poorly understood direct T-cell mediated mechanisms are more likely to be responsible</li>
<li>Higher incidence of reactions in patients with HIV/AIDS, tuberculosis</li>
</ul>
</section>
<section id="mechanism-of-sulfonamide-hypersensitivity" class="slide level2 smaller">
<h2>Mechanism of sulfonamide hypersensitivity</h2>
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/sulfallergy.png" class="lightbox" data-gallery="quarto-lightbox-gallery-40"><img data-src="images/sulfallergy.png" class="quarto-figure quarto-figure-center" width="800"></a></p>
</figure>
</div>

<aside><div>
<p><span class="citation" data-cites="slatore.tilles_2004">(<a href="#/references" role="doc-biblioref" onclick="">Slatore and Tilles, 2004</a>)</span></p>
</div></aside></section>
<section id="penfast-score-applied-to-sulfa-allergies" class="slide level2">
<h2>PENFAST score applied to sulfa allergies</h2>
<div class="quarto-figure quarto-figure-center">
<figure>
<p><a href="images/sulfast.png" class="lightbox" data-gallery="quarto-lightbox-gallery-41"><img data-src="images/sulfast.png" class="quarto-figure quarto-figure-center"></a></p>
</figure>
</div>
<div class=".aside">
<p><span class="citation" data-cites="waldron.etal_2023">(<a href="#/references" role="doc-biblioref" onclick="">Waldron et al., 2023</a>)</span></p>
</div>
</section>
<section id="summary" class="slide level2" data-background-image="images/nejm_allergy.png" data-background-opacity="0.2">
<h2>Summary</h2>
<p><br></p>
<ul>
<li>Penicillin allergies are the most common “contraindication” to antibiotic therapy, but most histories do not represent true allergies</li>
<li>A systematic approach can be used to evaluate and potentially “de-label” patients with penicillin allergy</li>
<li>Cross-reactivity rates are low with current cephalosporins and carbapenems, but can alternatively be addressed through antibiotic challenges and skin testing</li>
<li>Desensitization can be attempted in specific cases when a particular antibiotic is needed for IgE-mediated reactions</li>
<li>Some antibiotics cause non-immune-related hypersensitivity reactions that can be managed by slowing infusions and administering antihistamines</li>
</ul>
</section>
<section id="references" class="slide level2 smaller scrollable">
<h2>References</h2>
<p><br></p>
<div class="quarto-auto-generated-content">
<div class="footer footer-default">

</div>
</div>
<div class="hidden" aria-hidden="true">
<span class="glightbox-desc lightbox-desc-3">widespread macupapular</span>
<span class="glightbox-desc lightbox-desc-4">macupapular aspect</span>
<span class="glightbox-desc lightbox-desc-5">isolated follicular</span>
<span class="glightbox-desc lightbox-desc-6">coalescing erythema</span>
<span class="glightbox-desc lightbox-desc-7">urticaria</span>
<span class="glightbox-desc lightbox-desc-8">angioedema</span>
</div>
<div id="refs" class="references csl-bib-body" data-entry-spacing="0" role="list">
<div id="ref-castells.etal_2019" class="csl-entry" role="listitem">
Castells M, Khan DA, Phillips EJ. Penicillin allergy. New England Journal of Medicine 2019;381:2338–51. <a href="https://doi.org/10.1056/NEJMra1807761">https://doi.org/10.1056/NEJMra1807761</a>.
</div>
<div id="ref-copaescu.etal_2023" class="csl-entry" role="listitem">
Copaescu AM, Vogrin S, James F, Chua KYL, Rose MT, De Luca J, et al. Efficacy of a clinical decision rule to enable direct oral challenge in patients with low-risk penicillin allergy: The PALACE randomized clinical trial. JAMA Internal Medicine 2023;183:944–52. <a href="https://doi.org/10.1001/jamainternmed.2023.2986">https://doi.org/10.1001/jamainternmed.2023.2986</a>.
</div>
<div id="ref-hausmann.etal_2010" class="csl-entry" role="listitem">
Hausmann O, Schnyder B, Pichler WJ. Drug hypersensitivity reactions involving skin. In: Uetrecht J, editor. Adverse drug reactions, Springer; 2010, p. 29–55. <a href="https://doi.org/10.1007/978-3-642-00663-0_2">https://doi.org/10.1007/978-3-642-00663-0_2</a>.
</div>
<div id="ref-macy.etal_2023" class="csl-entry" role="listitem">
Macy E, Trautmann A, Chiriac AM, Demoly P, Phillips EJ. Advances in the understanding of drug hypersensitivity: 2012 through 2022. The Journal of Allergy and Clinical Immunology: In Practice 2023;11:80–91. <a href="https://doi.org/10.1016/j.jaip.2022.10.025">https://doi.org/10.1016/j.jaip.2022.10.025</a>.
</div>
<div id="ref-shenoy.etal_2019" class="csl-entry" role="listitem">
Shenoy ES, Macy E, Rowe T, Blumenthal KG. Evaluation and management of penicillin allergy: A review. JAMA: The Journal of the American Medical Association 2019;321:188–99. <a href="https://doi.org/10.1001/jama.2018.19283">https://doi.org/10.1001/jama.2018.19283</a>.
</div>
<div id="ref-slatore.tilles_2004" class="csl-entry" role="listitem">
Slatore CG, Tilles SA. Sulfonamide hypersensitivity. Immunology and Allergy Clinics of North America 2004;24:477–90, vii. <a href="https://doi.org/10.1016/j.iac.2004.03.011">https://doi.org/10.1016/j.iac.2004.03.011</a>.
</div>
<div id="ref-trubiano.etal_2020" class="csl-entry" role="listitem">
Trubiano JA, Vogrin S, Chua KYL, Bourke J, Yun J, Douglas A, et al. Development and validation of a penicillin allergy clinical decision rule. JAMA Internal Medicine 2020;180:745–52. <a href="https://doi.org/10.1001/jamainternmed.2020.0403">https://doi.org/10.1001/jamainternmed.2020.0403</a>.
</div>
<div id="ref-waldron.etal_2023" class="csl-entry" role="listitem">
Waldron JL, Rose M, Vogrin S, Krantz MS, Bolotte R, Phillips EJ, et al. Development and validation of a sulfa antibiotic allergy clinical decision rule. JAMA Network Open 2023;6:e2316776. <a href="https://doi.org/10.1001/jamanetworkopen.2023.16776">https://doi.org/10.1001/jamanetworkopen.2023.16776</a>.
</div>
<div id="ref-zhang.liu_2015" class="csl-entry" role="listitem">
Zhang Z, Liu X. Acute generalized exanthematous pustulosis. New England Journal of Medicine 2015;372:161–1. <a href="https://doi.org/10.1056/NEJMicm1401196">https://doi.org/10.1056/NEJMicm1401196</a>.
</div>
</div>
</section>
    </div>
  </div>

  <script>window.backupDefine = window.define; window.define = undefined;</script>
  <script src="Lecture1_files/libs/revealjs/dist/reveal.js"></script>
  <!-- reveal.js plugins -->
  <script src="Lecture1_files/libs/revealjs/plugin/quarto-line-highlight/line-highlight.js"></script>
  <script src="Lecture1_files/libs/revealjs/plugin/pdf-export/pdfexport.js"></script>
  <script src="Lecture1_files/libs/revealjs/plugin/reveal-menu/menu.js"></script>
  <script src="Lecture1_files/libs/revealjs/plugin/reveal-menu/quarto-menu.js"></script>
  <script src="Lecture1_files/libs/revealjs/plugin/reveal-chalkboard/plugin.js"></script>
  <script src="Lecture1_files/libs/revealjs/plugin/quarto-support/support.js"></script>
  

  <script src="Lecture1_files/libs/revealjs/plugin/notes/notes.js"></script>
  <script src="Lecture1_files/libs/revealjs/plugin/search/search.js"></script>
  <script src="Lecture1_files/libs/revealjs/plugin/zoom/zoom.js"></script>
  <script src="Lecture1_files/libs/revealjs/plugin/math/math.js"></script>
  <script>window.define = window.backupDefine; window.backupDefine = undefined;</script>

  <script>

      // Full list of configuration options available at:
      // https://revealjs.com/config/
      Reveal.initialize({
'controlsAuto': false,
'previewLinksAuto': false,
'pdfSeparateFragments': false,
'autoAnimateEasing': "ease",
'autoAnimateDuration': 1,
'autoAnimateUnmatched': true,
'menu': {"side":"left","useTextContentForMissingTitles":true,"markers":false,"loadIcons":false,"custom":[{"title":"Tools","icon":"<i class=\"fas fa-gear\"></i>","content":"<ul class=\"slide-menu-items\">\n<li class=\"slide-tool-item active\" data-item=\"0\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.fullscreen(event)\"><kbd>f</kbd> Fullscreen</a></li>\n<li class=\"slide-tool-item\" data-item=\"1\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.speakerMode(event)\"><kbd>s</kbd> Speaker View</a></li>\n<li class=\"slide-tool-item\" data-item=\"2\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.overview(event)\"><kbd>o</kbd> Slide Overview</a></li>\n<li class=\"slide-tool-item\" data-item=\"3\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.togglePdfExport(event)\"><kbd>e</kbd> PDF Export Mode</a></li>\n<li class=\"slide-tool-item\" data-item=\"4\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.toggleChalkboard(event)\"><kbd>b</kbd> Toggle Chalkboard</a></li>\n<li class=\"slide-tool-item\" data-item=\"5\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.toggleNotesCanvas(event)\"><kbd>c</kbd> Toggle Notes Canvas</a></li>\n<li class=\"slide-tool-item\" data-item=\"6\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.downloadDrawings(event)\"><kbd>d</kbd> Download Drawings</a></li>\n<li class=\"slide-tool-item\" data-item=\"7\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.keyboardHelp(event)\"><kbd>?</kbd> Keyboard Help</a></li>\n</ul>"}],"openButton":true},
'chalkboard': {"buttons":true},
'smaller': false,
 
        // Display controls in the bottom right corner
        controls: true,

        // Help the user learn the controls by providing hints, for example by
        // bouncing the down arrow when they first encounter a vertical slide
        controlsTutorial: false,

        // Determines where controls appear, "edges" or "bottom-right"
        controlsLayout: 'edges',

        // Visibility rule for backwards navigation arrows; "faded", "hidden"
        // or "visible"
        controlsBackArrows: 'faded',

        // Display a presentation progress bar
        progress: true,

        // Display the page number of the current slide
        slideNumber: 'c/t',

        // 'all', 'print', or 'speaker'
        showSlideNumber: 'all',

        // Add the current slide number to the URL hash so that reloading the
        // page/copying the URL will return you to the same slide
        hash: true,

        // Start with 1 for the hash rather than 0
        hashOneBasedIndex: false,

        // Flags if we should monitor the hash and change slides accordingly
        respondToHashChanges: true,

        // Push each slide change to the browser history
        history: true,

        // Enable keyboard shortcuts for navigation
        keyboard: true,

        // Enable the slide overview mode
        overview: true,

        // Disables the default reveal.js slide layout (scaling and centering)
        // so that you can use custom CSS layout
        disableLayout: false,

        // Vertical centering of slides
        center: false,

        // Enables touch navigation on devices with touch input
        touch: true,

        // Loop the presentation
        loop: false,

        // Change the presentation direction to be RTL
        rtl: false,

        // see https://revealjs.com/vertical-slides/#navigation-mode
        navigationMode: 'linear',

        // Randomizes the order of slides each time the presentation loads
        shuffle: false,

        // Turns fragments on and off globally
        fragments: true,

        // Flags whether to include the current fragment in the URL,
        // so that reloading brings you to the same fragment position
        fragmentInURL: false,

        // Flags if the presentation is running in an embedded mode,
        // i.e. contained within a limited portion of the screen
        embedded: false,

        // Flags if we should show a help overlay when the questionmark
        // key is pressed
        help: true,

        // Flags if it should be possible to pause the presentation (blackout)
        pause: true,

        // Flags if speaker notes should be visible to all viewers
        showNotes: false,

        // Global override for autoplaying embedded media (null/true/false)
        autoPlayMedia: null,

        // Global override for preloading lazy-loaded iframes (null/true/false)
        preloadIframes: null,

        // Number of milliseconds between automatically proceeding to the
        // next slide, disabled when set to 0, this value can be overwritten
        // by using a data-autoslide attribute on your slides
        autoSlide: 0,

        // Stop auto-sliding after user input
        autoSlideStoppable: true,

        // Use this method for navigation when auto-sliding
        autoSlideMethod: null,

        // Specify the average time in seconds that you think you will spend
        // presenting each slide. This is used to show a pacing timer in the
        // speaker view
        defaultTiming: null,

        // Enable slide navigation via mouse wheel
        mouseWheel: false,

        // The display mode that will be used to show slides
        display: 'block',

        // Hide cursor if inactive
        hideInactiveCursor: true,

        // Time before the cursor is hidden (in ms)
        hideCursorTime: 5000,

        // Opens links in an iframe preview overlay
        previewLinks: false,

        // Transition style (none/fade/slide/convex/concave/zoom)
        transition: 'fade',

        // Transition speed (default/fast/slow)
        transitionSpeed: 'fast',

        // Transition style for full page slide backgrounds
        // (none/fade/slide/convex/concave/zoom)
        backgroundTransition: 'none',

        // Number of slides away from the current that are visible
        viewDistance: 3,

        // Number of slides away from the current that are visible on mobile
        // devices. It is advisable to set this to a lower number than
        // viewDistance in order to save resources.
        mobileViewDistance: 2,

        // The "normal" size of the presentation, aspect ratio will be preserved
        // when the presentation is scaled to fit different resolutions. Can be
        // specified using percentage units.
        width: 1050,

        height: 700,

        // Factor of the display size that should remain empty around the content
        margin: 0.1,

        math: {
          mathjax: 'https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.0/MathJax.js',
          config: 'TeX-AMS_HTML-full',
          tex2jax: {
            inlineMath: [['\\(','\\)']],
            displayMath: [['\\[','\\]']],
            balanceBraces: true,
            processEscapes: false,
            processRefs: true,
            processEnvironments: true,
            preview: 'TeX',
            skipTags: ['script','noscript','style','textarea','pre','code'],
            ignoreClass: 'tex2jax_ignore',
            processClass: 'tex2jax_process'
          },
        },

        // reveal.js plugins
        plugins: [QuartoLineHighlight, PdfExport, RevealMenu, RevealChalkboard, QuartoSupport,

          RevealMath,
          RevealNotes,
          RevealSearch,
          RevealZoom
        ]
      });
    </script>
    <script id="quarto-html-after-body" type="application/javascript">
    window.document.addEventListener("DOMContentLoaded", function (event) {
      const toggleBodyColorMode = (bsSheetEl) => {
        const mode = bsSheetEl.getAttribute("data-mode");
        const bodyEl = window.document.querySelector("body");
        if (mode === "dark") {
          bodyEl.classList.add("quarto-dark");
          bodyEl.classList.remove("quarto-light");
        } else {
          bodyEl.classList.add("quarto-light");
          bodyEl.classList.remove("quarto-dark");
        }
      }
      const toggleBodyColorPrimary = () => {
        const bsSheetEl = window.document.querySelector("link#quarto-bootstrap");
        if (bsSheetEl) {
          toggleBodyColorMode(bsSheetEl);
        }
      }
      toggleBodyColorPrimary();  
      const tabsets =  window.document.querySelectorAll(".panel-tabset-tabby")
      tabsets.forEach(function(tabset) {
        const tabby = new Tabby('#' + tabset.id);
      });
      const isCodeAnnotation = (el) => {
        for (const clz of el.classList) {
          if (clz.startsWith('code-annotation-')) {                     
            return true;
          }
        }
        return false;
      }
      const clipboard = new window.ClipboardJS('.code-copy-button', {
        text: function(trigger) {
          const codeEl = trigger.previousElementSibling.cloneNode(true);
          for (const childEl of codeEl.children) {
            if (isCodeAnnotation(childEl)) {
              childEl.remove();
            }
          }
          return codeEl.innerText;
        }
      });
      clipboard.on('success', function(e) {
        // button target
        const button = e.trigger;
        // don't keep focus
        button.blur();
        // flash "checked"
        button.classList.add('code-copy-button-checked');
        var currentTitle = button.getAttribute("title");
        button.setAttribute("title", "Copied!");
        let tooltip;
        if (window.bootstrap) {
          button.setAttribute("data-bs-toggle", "tooltip");
          button.setAttribute("data-bs-placement", "left");
          button.setAttribute("data-bs-title", "Copied!");
          tooltip = new bootstrap.Tooltip(button, 
            { trigger: "manual", 
              customClass: "code-copy-button-tooltip",
              offset: [0, -8]});
          tooltip.show();    
        }
        setTimeout(function() {
          if (tooltip) {
            tooltip.hide();
            button.removeAttribute("data-bs-title");
            button.removeAttribute("data-bs-toggle");
            button.removeAttribute("data-bs-placement");
          }
          button.setAttribute("title", currentTitle);
          button.classList.remove('code-copy-button-checked');
        }, 1000);
        // clear code selection
        e.clearSelection();
      });
        var localhostRegex = new RegExp(/^(?:http|https):\/\/localhost\:?[0-9]*\//);
        var mailtoRegex = new RegExp(/^mailto:/);
          var filterRegex = new RegExp('/' + window.location.host + '/');
        var isInternal = (href) => {
            return filterRegex.test(href) || localhostRegex.test(href) || mailtoRegex.test(href);
        }
        // Inspect non-navigation links and adorn them if external
     	var links = window.document.querySelectorAll('a[href]:not(.nav-link):not(.navbar-brand):not(.toc-action):not(.sidebar-link):not(.sidebar-item-toggle):not(.pagination-link):not(.no-external):not([aria-hidden]):not(.dropdown-item):not(.quarto-navigation-tool)');
        for (var i=0; i<links.length; i++) {
          const link = links[i];
          if (!isInternal(link.href)) {
            // undo the damage that might have been done by quarto-nav.js in the case of
            // links that we want to consider external
            if (link.dataset.originalHref !== undefined) {
              link.href = link.dataset.originalHref;
            }
          }
        }
      function tippyHover(el, contentFn, onTriggerFn, onUntriggerFn) {
        const config = {
          allowHTML: true,
          maxWidth: 500,
          delay: 100,
          arrow: false,
          appendTo: function(el) {
              return el.closest('section.slide') || el.parentElement;
          },
          interactive: true,
          interactiveBorder: 10,
          theme: 'light-border',
          placement: 'bottom-start',
        };
        if (contentFn) {
          config.content = contentFn;
        }
        if (onTriggerFn) {
          config.onTrigger = onTriggerFn;
        }
        if (onUntriggerFn) {
          config.onUntrigger = onUntriggerFn;
        }
          config['offset'] = [0,0];
          config['maxWidth'] = 700;
        window.tippy(el, config); 
      }
      const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
      for (var i=0; i<noterefs.length; i++) {
        const ref = noterefs[i];
        tippyHover(ref, function() {
          // use id or data attribute instead here
          let href = ref.getAttribute('data-footnote-href') || ref.getAttribute('href');
          try { href = new URL(href).hash; } catch {}
          const id = href.replace(/^#\/?/, "");
          const note = window.document.getElementById(id);
          if (note) {
            return note.innerHTML;
          } else {
            return "";
          }
        });
      }
      const findCites = (el) => {
        const parentEl = el.parentElement;
        if (parentEl) {
          const cites = parentEl.dataset.cites;
          if (cites) {
            return {
              el,
              cites: cites.split(' ')
            };
          } else {
            return findCites(el.parentElement)
          }
        } else {
          return undefined;
        }
      };
      var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
      for (var i=0; i<bibliorefs.length; i++) {
        const ref = bibliorefs[i];
        const citeInfo = findCites(ref);
        if (citeInfo) {
          tippyHover(citeInfo.el, function() {
            var popup = window.document.createElement('div');
            citeInfo.cites.forEach(function(cite) {
              var citeDiv = window.document.createElement('div');
              citeDiv.classList.add('hanging-indent');
              citeDiv.classList.add('csl-entry');
              var biblioDiv = window.document.getElementById('ref-' + cite);
              if (biblioDiv) {
                citeDiv.innerHTML = biblioDiv.innerHTML;
              }
              popup.appendChild(citeDiv);
            });
            return popup.innerHTML;
          });
        }
      }
    });
    </script>
    <script>var lightboxQuarto = GLightbox({"closeEffect":"zoom","descPosition":"bottom","selector":".lightbox","openEffect":"zoom","loop":false});
    window.onload = () => {
      lightboxQuarto.on('slide_before_load', (data) => {
        const { slideIndex, slideNode, slideConfig, player, trigger } = data;
        const href = trigger.getAttribute('href');
        if (href !== null) {
          const imgEl = window.document.querySelector(`a[href="${href}"] img`);
          if (imgEl !== null) {
            const srcAttr = imgEl.getAttribute("src");
            if (srcAttr && srcAttr.startsWith("data:")) {
              slideConfig.href = srcAttr;
            }
          }
        } 
      });

      lightboxQuarto.on('slide_after_load', (data) => {
        const { slideIndex, slideNode, slideConfig, player, trigger } = data;
        if (window.Quarto?.typesetMath) {
          window.Quarto.typesetMath(slideNode);
        }
      });

    };
              </script>
    

</body></html>